| Company Name: | Elron Electronic Industries LTD. | | Ticker Symbol: | ELRN | | | WWW Address: | www.elron.com | | CEO: | Dr. Zvika Slovin, Ph.D. | | No. of Employees: | 27 | | Common Issue Type: | CS | | Business Description: | A high technology operational holding company, engaged in the fields of medical devices, information communications, technology, semiconductors and clean technology.
|
| | | Industry Information: | COMPUTER SOFWARE & SERVICES - Information Technology Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 7.18 |  0.19 | 6.44 | 7.2 | 7.0 | 6.99 | 6.76 | 57279 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 213.2 | 29.7 | 1.58 | -2.94 | 0.00 | 0.0 | 0.0 | 8.43 - 1.14 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 6.99 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 207.3 | mil |
| Latest Shares Outstanding | 29.7 | mil |
| Earnings pS (EPS) | -2.94 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 231,000 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | 0.0 | % |
| Foreign Sales | 3 | mil |
| Domestic Sales | 3 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.0 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 0.0 | % |
| Current Ratio | 1.4 | |
| Leverage Ratio (Assets/Equity) | 1.6 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.40 | |
| LT Debt/Total Capital | 27.0 | % |
| Working Capital pS | 0.26 | $ |
| Cash pS | 0.57 | $ |
| Book-Value pS | 5.36 | $ |
| Tangible Book-Value pS | 5.11 | $ |
| Cash Flow pS | -2.71 | $ |
| Free Cash Flow pS | -2.64 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.31 | |
| Price/Tangible Book Ratio | 1.37 | |
| Price/Cash Flow | -2.6 | |
| Price/Free Cash Flow | -2.6 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 09/05/2005 |
| Dividend Ex-Date | 09/15/2005 |
| Dividend Record Date | 09/14/2005 |
| Dividend Pay Date | 09/26/2005 |
| Dividend Amount | 3000 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 38.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.9 | 103 | 575 | 1,627 |
| 4 Weeks | 7.19 | 6.24 | 6.08 | 15.0 | 114 | 552 | 11,047 |
| 13 Weeks | 7.19 | 4.35 | 5.11 | 36.8 | 129 | 422 | 26,998 |
| 26 Weeks | 8.43 | 2.62 | 2.94 | 137.8 | 193 | 731 | 92,867 |
| 52 Weeks | 8.43 | 1.14 | 1.17 | 497.4 | 438 | 529 | 132,849 |
| YTD | 8.43 | 1.36 | - | 433.6 | 442 | 529 | 119,023 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 6.93 | 6.92 | 6.04 | 4.48 | 3.84 | 1.58 | 1.60 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -22.27 | 73.3 | -27.38 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 91.16 | NA | 169.12 |
| R&D | 52.39 | NA | 61.42 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 42.7 | 123.3 | 42.7 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -1.67 | -0.50 | -1.67 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 2.79 |
| Current Ratio | 1.4 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.91 |
| Receivables Turnover | 1.7 |
| Average Collection Period | 212 |
| Working Capital/Equity | 4.1 |
| Working Capital pS | 0.24 |
| Cash-Flow pS | -2.71 |
| Free Cash-Flow pS | -2.64 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -0.18 |
| Financial Leverage Ratio (Assets/Equity) | 1.5 |
| Debt Ratio | 31.9 |
| Total Debt/Equity (Gearing Ratio) | 0.26 |
| LT Debt/Equity | 0.24 |
| LT Debt/Capital Invested | 29.0 |
| LT Debt/Total Liabilities | 52.1 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.69 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 4.16 |
| Tobin's Q Ratio | 0.80 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -5.26 |
| Enterprise Value (EV)/Free Cash Flow | -2.51 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 1.37 |
| Price/Book Ratio - LTM | 1.31 |
| Price/Cash Flow Ratio | -2.6 |
| Price/Free Cash Flow Ratio - LTM | -2.6 |
| Price/Sales Ratio | 33.23 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 1.46 |
| Current Liabilities pS | 0.65 |
| Tangible Book Value pS - LTM | 5.11 |
| Book Value pS - LTM | 5.36 |
| Capital Invested pS | 7.45 |
| Cash pS - LTM | 0.57 |
| Cash Flow pS - LTM | -2.71 |
| Free Cash Flow pS - LTM | -2.64 |
| Earnings pS (EPS) | -2.94 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -1,254.03 |
| Free Cash Flow Margin 5YEAR AVG | -618.86 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 21.5 |
| Equity Productivity | 0.04 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.8 |
| Capital Invested Productivity | 0.03 |
| Return on Capital Invested (ROCI) | -39.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.8 |
| Assets Productivity | 0.00 |
| Return on Assets (ROA) | -33.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.6 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 54.0 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 38.9 |
| Effective Tax Rate | -1.3 |
| Effective Tax Rate - 5YEAR AVRG. | -2.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 322 |
| Revenue per Employee | 231,000 |
| Net Income per Employee | -3,190,889 |
| Average Collection Period | 66 |
| Receivables Turnover | 1.7 |
| Day's Inventory Turnover Ratio | 256 |
| Inventory Turnover | 1.4 |
| Inventory/Sales | 32.1 |
| Accounts Payble/Sales | 251.32 |
| Assets/Revenue | 0.00 |
| Net Working Capital Turnover | 0.86 |
| Fixed Assets Turnover | 0.03 |
| Total Assets Turnover | 0.0 |
| Revenue per $ Cash | 0.36 |
| Revenue per $ Plant | 1.36 |
| Revenue per $ Common Equity | 0.04 |
| Revenue per $ Capital Invested | 0.03 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 422.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 169.1 |
| Research & Devlopment (R&D) as % of Revenue | 468.1 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 468.1 |
|
|  
|
| |
 |  |